Asset Prioritization

Objective :

Asset Prioritization Analysis to provide Strategic direction to the client in Atrial Fibrillation space along with Identification of best possible asset to support client’s future development and licensing needs.

Problem Statement:

A mid-sized pharma client was working to develop their asset portfolio and was interested in assessing best possible asset for atrial fibrillation for future development and licensing needs. The client requested evidence-based priorities in assets and products for Phase II development in atrial fibrillation, through potential licensing collaborations. Also, the client wanted to prioritise research efforts to determine the best possible asset to leverage their research portfolio.

Our Methodology:

• Technology Assessment
• Company Assessment
• Commercial Assessment
• Clinical Assessment
• Primary Assessment
• Matrix Analysis
• Best Possible Asset Identified

Results:

• Matrix Analysis positioned the top 20 companies researched.
• The client could assess the Top companies which would effectively fit their strategic needs and objectives (the TARGET quadrant).
• Insights into market trends for different candidates the company is developing and helping to prioritise the products.